The boss of the AIM-listed drug discovery group explains that Astra do all the work on SNG001 from here, which will give Synairgen the chance to boost its drug pipeline and hopefully repeat the trick in future.
Synairgen chief thrilled with AstraZeneca deal
Quick facts: Synairgen PLC
Price: 174 GBX
Market Cap: £347.85 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Synairgen PLC named herein, including the promotion by the Company of Synairgen PLC in any Content on the Site, the Company receives from said...FOR OUR FULL DISCLAIMER CLICK HERE